California courts have jurisdiction over 575 out-of-state plaintiffs suing Bristol-Myers Squibb for alleged defects in Plavix, the California First District Court of Appeal has ruled.
Plavix cases involving 84 California plaintiffs and the out-of-state plaintiffs have been coordinated in the San Francisco Superior Court. BMS is headquartered in New York.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
